Marina Aweeda, Carly Fassler, Daniel R S Habib, Alexis B Miller, Carlos Ortega, Kavita Prasad, Chiu-Lan Chen, Sara H Duffus, Ryan H Belcher
{"title":"Risk Factors and Rates for Hypocalcemia After Pediatric Thyroidectomy: A Systematic Review and Meta-analysis.","authors":"Marina Aweeda, Carly Fassler, Daniel R S Habib, Alexis B Miller, Carlos Ortega, Kavita Prasad, Chiu-Lan Chen, Sara H Duffus, Ryan H Belcher","doi":"10.1002/oto2.70130","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Postoperative hypocalcemia after total thyroidectomy (TT) affects pediatric patients at higher rates than adult patients, yet its rate remains poorly defined. This study aims to determine the rates of transient, permanent, and any hypocalcemia after TT in pediatric patients and analyze potential risk factors.</p><p><strong>Data sources: </strong>PubMed, EMBASE, Scopus, and Cochrane.</p><p><strong>Review methods: </strong>A database search was conducted through March 2024 according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Data concerning postoperative hypocalcemia, risk factors, and clinical context were collected and analyzed. Transient hypocalcemia was defined as lasting less than 6 months and permanent as lasting greater than 6 months after surgery.</p><p><strong>Results: </strong>In total, 67 studies with 7331 pediatric patients met the inclusion criteria. Surgical indications for TT in this cohort included malignant conditions (54.75%), benign conditions (19.70%), Graves' disease (18.59%), genetic syndromes (MEN2A/2B, RET mutation) (6.04%), and Hashimoto's thyroiditis (0.92%). The pooled incidence rates were 25.2% (95% CI 0.20-0.31) for transient, 7.4% (95% CI 0.05-0.10) for permanent, and 32.1% (95% CI 0.26-0.39) for any hypocalcemia. Fifteen of the included studies also examined risk factors for postoperative hypocalcemia. Patients undergoing TT for malignancy (odds ratio [OR] 2.82, 95% CI [1.18-6.73]; <i>P</i> = .02) or Graves' disease (OR 6.12, 95% CI [3.10-12.01]; <i>P</i> < .0001), as well as those undergoing any lymph node dissection (OR 3.71, 95% CI [1.95-7.06]; <i>P</i> < .0001) were at higher risk for postoperative hypocalcemia.</p><p><strong>Conclusion: </strong>Hypocalcemia is a common postoperative complication of TT in pediatric patients. Risk factors include malignant surgical indication, Graves' disease, and any lymph node dissection.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"9 2","pages":"e70130"},"PeriodicalIF":1.8000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100633/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"OTO Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/oto2.70130","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Postoperative hypocalcemia after total thyroidectomy (TT) affects pediatric patients at higher rates than adult patients, yet its rate remains poorly defined. This study aims to determine the rates of transient, permanent, and any hypocalcemia after TT in pediatric patients and analyze potential risk factors.
Data sources: PubMed, EMBASE, Scopus, and Cochrane.
Review methods: A database search was conducted through March 2024 according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Data concerning postoperative hypocalcemia, risk factors, and clinical context were collected and analyzed. Transient hypocalcemia was defined as lasting less than 6 months and permanent as lasting greater than 6 months after surgery.
Results: In total, 67 studies with 7331 pediatric patients met the inclusion criteria. Surgical indications for TT in this cohort included malignant conditions (54.75%), benign conditions (19.70%), Graves' disease (18.59%), genetic syndromes (MEN2A/2B, RET mutation) (6.04%), and Hashimoto's thyroiditis (0.92%). The pooled incidence rates were 25.2% (95% CI 0.20-0.31) for transient, 7.4% (95% CI 0.05-0.10) for permanent, and 32.1% (95% CI 0.26-0.39) for any hypocalcemia. Fifteen of the included studies also examined risk factors for postoperative hypocalcemia. Patients undergoing TT for malignancy (odds ratio [OR] 2.82, 95% CI [1.18-6.73]; P = .02) or Graves' disease (OR 6.12, 95% CI [3.10-12.01]; P < .0001), as well as those undergoing any lymph node dissection (OR 3.71, 95% CI [1.95-7.06]; P < .0001) were at higher risk for postoperative hypocalcemia.
Conclusion: Hypocalcemia is a common postoperative complication of TT in pediatric patients. Risk factors include malignant surgical indication, Graves' disease, and any lymph node dissection.
目的:甲状腺全切除术(TT)后儿童患者低钙发生率高于成人患者,但其发生率仍不明确。本研究旨在确定儿科患者TT后短暂性、永久性和任何低钙血症的发生率,并分析潜在的危险因素。数据来源:PubMed, EMBASE, Scopus和Cochrane。评价方法:根据系统评价和荟萃分析(PRISMA)指南的首选报告项目,在2024年3月之前进行数据库搜索。收集和分析有关术后低钙、危险因素和临床背景的数据。短暂性低钙血症定义为术后持续时间小于6个月,永久性低钙血症定义为术后持续时间大于6个月。结果:共有67项研究7331例儿童患者符合纳入标准。该队列中TT的手术指征包括恶性(54.75%)、良性(19.70%)、Graves病(18.59%)、遗传综合征(MEN2A/2B、RET突变)(6.04%)和桥本甲状腺炎(0.92%)。短暂性的总发病率为25.2% (95% CI 0.20-0.31),永久性的为7.4% (95% CI 0.05-0.10),任何低钙血症的总发病率为32.1% (95% CI 0.26-0.39)。纳入的研究中有15项还检查了术后低钙血症的危险因素。因恶性肿瘤接受TT治疗的患者(优势比[OR] 2.82, 95% CI [1.18-6.73];P = .02)或Graves病(or 6.12, 95% CI [3.10-12.01];结论:低钙血症是小儿TT术后常见的并发症。危险因素包括恶性手术指征、Graves病和任何淋巴结清扫。